Latest News and Press Releases
Want to stay updated on the latest news?
-
SHANGHAI, China and CUPERTINO, Calif., April 10, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (CBMG or the Company), a leading clinical-stage biopharmaceutical firm engaged...
-
SHANGHAI, China and CUPERTINO, Calif., March 30, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a leading clinical-stage biopharmaceutical firm...
-
SHANGHAI, China and CUPERTINO, Calif., March 21, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm...
-
Embarked On GMP Expansion To Become One Of The Largest In-House CAR-T Manufacturers in Terms of Capacity Amongst Leading Biopharmaceutical Companies In The WorldCommenced Two CAR-T Phase I Clinical...
-
SHANGHAI, China and CUPERTINO, Calif., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged...
-
SHANGHAI, China and CUPERTINO, Calif., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm...
-
SHANGHAI, China and CUPERTINO, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firm engaged in the...
-
SHANGHAI, China and CUPERTINO, Calif., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firm engaged in...
-
SHANGHAI, China and CUPERTINO, Calif., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firm engaged in...
-
- No Serious Adverse Events Observed- SHANGHAI, China and CUPERTINO, Calif., Dec. 09, 2016 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a...